|
|
(Journal Article): Increased Transcriptional Preproinsulin II Beta-Cell Activity in Neonatal Nonobese Diabetic Mice: In Situ Hybridization Analysis
Throsby M, Coulaud J, Durant S, Homo-Delarche F (Crucell Holland B.V., Leiden 2301 CA, The Netherlands,
francoise.homo-delarche(at)paris7.jussieu.fr
)
IN:
Rev Diabetic Stud
2005; 2(2):75-83
Impact Factor(s) of Rev Diabetic Stud: 0.125 (2006)
Fulltext:
HTML
PDF
ABSTRACT: In the prediabetic nonobese diabetic (NOD) mouse, a spontaneous model of type 1 diabetes, we previously reported transient postweaning hyperinsulinemia followed by progressive islet hyperplasia. A modified in situ hybridization technique was used to determine whether these effects were accompanied by changes in insulin transcriptional activity as a function of age. We found that NOD neonates express higher levels of preproinsulin II primary transcripts than age-matched C57BL/6 mice, but this difference disappeared within the first wk of age. To manipulate insulin transcriptional activity in NOD neonates, NOD mothers were treated with insulin during the last two wk of gestation. A down-regulation of β-cell hyperactivity was observed in female NOD neonates but not in male neonates. By contrast, the same insulin treatment applied to NODscid (severe combined immunodeficiency) mothers, devoid of functional lymphocytes but showing like NOD mice postweaning hyperinsulinemia, increased transcriptional β-cell activity in both sexes of neonates. In conclusion, NOD mice exhibit successive and transient signs of β-cell hyperactivity, reflected as early as birth by high transcriptional preproinsulin II activity and later, from weaning to around 10 wk of age, by hyperinsulinemia. Of note, when thinking in terms of in utero disease programming, the NOD neonatal transcriptional β-cell hyperactivity could be modulated by environmental (maternal and/or fetal) factors.
TYPE OF PUBLICATION: Original article
REFERENCES:
- Bach JF. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr Rev 1994. 15:516-542.
[DOD]
- Homo-Delarche F. Neuroendocrine immuno-ontogeny of the pathogenesis of autoimmune disease in the nonobese diabetic (NOD) mouse. Ilar J 2004. 45:237-258.
[DOD]
- Rossini AA, Handler ES, Mordes JP, Greiner DL. Human autoimmune diabetes mellitus: lessons from BB rats and NOD mice - caveat emptor. Clin Immunol Immunopathol 1995. 74:2-9.
[DOD]
- Anderson MS, Bluestone JA. The NOD mouse: a model of immune dysregulation. Annu Rev Immunol 2005. 23:447-485.
- Delovitch TL, Singh B. The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity 1997. 7:727-738.
[DOD]
- Rosmalen JG, van Ewijk W, Leenen PJ. T-cell education in autoimmune diabetes: teachers and students. Trends Immunol 2002. 23:40-46.
[DOD]
- Homo-Delarche F, Boitard C. Autoimmune diabetes: the role of the islets of Langerhans. Immunol Today 1996. 17:456-460.
[DOD]
- Rosmalen JG, Leenen PJ, Pelegri C, Drexhage HA, Homo-Delarche F. Islet abnormalities in the pathogenesis of autoimmune diabetes. Trends Endocrinol Metab 2002. 13:209-214.
[DOD]
- Jansen A, Homo-Delarche F, Hooijkaas H, Leenen PJ, Dardenne M, Drexhage HA. Immunohistochemical characterization of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis and beta-cell destruction in NOD mice. Diabetes 1994. 43:667-675.
[DOD]
- Amrani A, Durant S, Throsby M, Coulaud J, Dardenne M, Homo-Delarche F. Glucose homeostasis in the nonobese diabetic mouse at the prediabetic stage. Endocrinology 1998. 139:1115-1124.
[DOD]
- Homo-Delarche F, Drexhage HA. Immune cells, pancreas development, regeneration and type 1 diabetes. Trends Immunol 2004. 25:222-229.
[DOD]
- Jansen A, Rosmalen JG, Homo-Delarche F, Dardenne M, Drexhage HA. Effect of prophylactic insulin treatment on the number of ER-MP23+ macrophages in the pancreas of NOD mice. Is the prevention of diabetes based on beta-cell rest? J Autoimmun 1996. 9:341-348.
- Blazquez E, Montoya E, Lopez Quijada C. Relationship between insulin concentrations in plasma and pancreas of foetal and weaning rats. J Endocrinol 1970. 48:553-561.
- Homo-Delarche F. Beta-cell behaviour during the prediabetic stage. Part II. Non-insulin-dependent and insulin-dependent diabetes mellitus. Diabetes Metab 1997. 23:473-505.
- Zucker P, Logothetopoulos J. Persisting enhanced proinsulin-insulin and protein biosynthesis (3H-leucine incorporation) by pancreatic islets of the rat after glucose exposure. Diabetes 1975. 24:194-200.
- Fujimoto S, Tsuura Y, Ishida H, Tsuji K, Mukai E, Kajikawa M, Hamamoto Y, Takeda T, Yamada Y, Seino Y. Augmentation of basal insulin release from rat islets by preexposure to a high concentration of glucose. Am J Physiol Endocrinol Metab 2000. 279:E927-940.
- Philippe J. Structure and pancreatic expression of the insulin and glucagon genes. Endocr Rev 1991. 12:252-271.
- Fremeau RT Jr, Lundblad JR, Pritchett DB, Wilcox JN, Roberts JL. Regulation of pro-opiomelanocortin gene transcription in individual cell nuclei. Science 1986. 234:1265-1269.
- Prochazka M, Gaskins HR, Shultz LD, Leiter EH. The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency. Proc Natl Acad Sci U S A 1992. 89:3290-3294.
- Rosmalen JG, Pigmans MJ, Kersseboom R, Drexhage HA, Leenen PJ, Homo-Delarche F. Sex steroids influence pancreatic islet hypertrophy and subsequent autoimmune infiltration in nonobese diabetic (NOD) and NODscid mice. Lab Invest 2001. 81:231-239.
- Calvo RM, Forcen R, Obregon MJ, Escobar del Rey F, Morreale de Escobar G, Regadera J. Immunohistochemical and morphometric studies of the fetal pancreas in diabetic pregnant rats. Effects of insulin administration. Anat Rec 1998. 251:173-180.
- Pelegri C, Rosmalen JG, Durant S, Throsby M, Alves V, Coulaud J, Esling A, Pleau JM, Drexhage HA, Homo-Delarche F. Islet endocrine-cell behavior from birth onward in mice with the nonobese diabetic genetic background. Mol Med 2001. 7:311-319.
- Throsby M, Homo-Delarche F, Chevenne D, Goya R, Dardenne M, Pleau JM. Pancreatic hormone expression in the murine thymus: localization in dendritic cells and macrophages. Endocrinology 1998. 139:2399-2406.
- Homo-Delarche F. Beta-cell behavior during the prediabetic stage. Part I. Beta-cell pathophysiology. Diabetes Metab 1997. 23:181-194.
- Weisz J, Ward IL. Plasma testosterone and progesterone titers of pregnant rats, their male and female fetuses, and neonatal offspring. Endocrinology 1980. 106:306-316.
- Lavine RL, Chick WL, Like AA, Makdisi TW. Glucose tolerance and insulin secretion in neonatal and adult mice. Diabetes 1971. 20:134-139.
- Leiter EH. The genetics of diabetes susceptibility in mice. Faseb J 1989. 3:2231-2241.
- Bauman WA, Yalow RS. Transplacental passage of insulin complexed to antibody. Proc Natl Acad Sci U S A 1981. 78:4588-4590.
- Michel C, Boitard C, Bach JF. Insulin autoantibodies in non-obese diabetic (NOD) mice. Clin Exp Immunol 1989. 75:457-460.
- Reddy S, Bibby N, Elliott RB. Longitudinal study of islet cell antibodies and insulin autoantibodies and development of diabetes in non-obese diabetic (NOD) mice. Clin Exp Immunol 1990. 81:400-405.
- Boden G, Chen X, DeSantis R, Kolaczynski J, Morris M. Evidence that suppression of insulin secretion by insulin itself is neurally mediated. Metabolism 1993. 42:786-789.
- Dorner G, Plagemann A. Perinatal hyperinsulinism as possible predisposing factor for diabetes mellitus, obesity and enhanced cardiovascular risk in later life. Horm Metab Res 1994. 26:213-221.
- Strubbe JH, Steffens AB. Neural control of insulin secretion. Horm Metab Res 1993. 25:507-512.
- Xu GG, Rothenberg PL. Insulin receptor signaling in the beta-cell influences insulin gene expression and insulin content: evidence for autocrine beta-cell regulation. Diabetes 1998. 47:1243-1252.
- Gerich JE. Lilly lecture 1988. Glucose counterregulation and its impact on diabetes mellitus. Diabetes 1988. 37:1608-1617.
[DOD]
- Homo-Delarche F, Coulaud J, Durant S, Drexhage HA. Glucose homeostasis in the nonobese diabetic mouse, a spontaneous model of type 1 diabetes, and lymphocyte-deficient NODscid mice during gestation. Diabetologia 2004. 47 suppl I:A182.
- Zeidler A, Tosco C, Kumar D, Slavin B, Parker J. Spontaneous hyperglycemia and impaired glucose tolerance in athymic nude BALB/c mice. Diabetes 1982. 31:821-825.
- Zeidler A, Shargill NS, Chan TM. Peripheral insulin insensitivity in the hyperglycemic athymic nude mouse: similarity to noninsulin-dependent diabetes mellitus. Proc Soc Exp Biol Med 1991. 196:457-460.
- Wilson SS, DeLuca D. NOD fetal thymus organ culture: an in vitro model for the development of T cells involved in IDDM. J Autoimmun 1997. 10:461-472.
- Saravia-Fernandez F, Durant S, el Hasnaoui A, Dardenne M, Homo-Delarche F. Environmental and experimental procedures leading to variations in the incidence of diabetes in the nonobese diabetic (NOD) mouse. Autoimmunity 1996. 24:113-121.
- Charre S, Rosmalen JG, Pelegri C, Alves V, Leenen PJ, Drexhage HA, Homo-Delarche F. Abnormalities in dendritic cell and macrophage accumulation in the pancreas of nonobese diabetic (NOD) mice during the early neonatal period. Histol Histopathol 2002. 17:393-401.
- Senecat O, Martignat L, Elmansour A, Charbonnel B, Sai P. Diabetes enhancement and increased islet antigen expression following neonatal injections of glucose and arginine in non-obese diabetic mice. Metabolism 1994. 43:1410-1418.
- Dahlquist G, Kallen B. Early neonatal events and the disease incidence in nonobese diabetic mice. Pediatr Res 1997. 42:489-491.
- Leslie RD, Taylor R, Pozzilli P. The role of insulin resistance in the natural history of type 1 diabetes. Diabet Med 1997. 14:327-331.
- Greenbaum CJ. Insulin resistance in type 1 diabetes. Diabetes Metab Res Rev 2002. 18:192-200.
[DOD]
- Wilkin TJ. The accelerator hypothesis: weight gain as the missing link between Type I and Type II diabetes. Diabetologia 2001. 44:914-922.
- Fourlanos S, Narendran P, Byrnes GB, Colman PG, Harrison LC. Insulin resistance is a risk factor for progression to type 1 diabetes. Diabetologia 2004. 47:1661-1667.
|
Respond
on this Journal Article!
Hint: Your Response should directly apply to Increased Transcriptional Preproinsulin II Beta-Cell Activity in Neonatal Nonobese Diabetic Mice: In Situ Hybridization Analysis.
Please check, if this context applies best to your contribution. Otherwise click HERE to change to the appropriate
subject area. The actual subject area is Hyperinsulinemia.
|
|
|
|
|